Barbara Sahakian

Barbara Sahakian

Smart Drugs

Professor Barbara J Sahakian FMedSci

Barbara J Sahakian is Professor of Clinical Neuropsychology at the University of Cambridge Department of Psychiatry and MRC / Wellcome Trust Behavioural and Clinical Neuroscience Institute. She is also an Honorary Clinical Psychologist at Addenbrooke’s Hospital, Cambridge, UK. She is President of the British Association for Psychopharmacology. She is a Founder Member and on the Executive Board of the International Neuroethics Society (INS). She has just become President-Elect of the INS. She is co-author of ‘Bad Moves. How decision making goes wrong and the ethics of smart drugs.’ (Oxford University Press, 2013) and co-editor of The Oxford Handbook of Neuroethics (Oxford University Press, 2011).

Professor Sahakian has an international reputation in the fields of psychopharmacology, neuropsychology and neuropsychiatry and it is the research at the interaction of these for which she has made outstanding and novel contributions.  More recently, she has also gained an international reputation in the engagement of the public in science, the newly developing field of neuroethics and neuroscience and mental health policy.  Her research has been applied in the development of the scientific invention: CANTAB (Cambridge Neuropsychological Test Automated Battery (;; ). She co-invented these computerized tests, which are now used in over 500 universities, institutes and hospitals in over 50 countries worldwide.

Professor Sahakian has over 350 publications in high impact scientific journals, covering topics in psychopharmacology, neuropsychology, neuropsychiatry, neuroimaging and neuroethics. The ISI Web of Science database credits her with a Hirsch (h) index of 88, with some of her publications having over 300 citations.  Indeed, her total citations are 23,769 and she has 74 published articles with more than 100 citations.